RP Management, LLC
- SEC CIK
- 0001507673
- Latest filing
- Aug 6, 2025
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 3
- −1 vs. Q2 2022
- Portfolio value
- $216.4M
- −$33.0M (−13.2%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 1,111,111 | $168.0M | 77.6% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,846,154 | $48.5M | 22.4% | 00.0% | Unchanged | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,700 | $16.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2022 (1)
Positions held at the end of Q2 2022 that are gone from this filing.